Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2061 (LINC02061)

Target
LINC02061
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), subclass lincRNA
01

Overview

Long intergenic non-protein coding RNA 2061 (LINC02061) is a human gene that encodes a long intergenic non-coding RNA (lincRNA) transcript[1]. LincRNAs are defined as autonomously transcribed RNAs greater than 200 nucleotides in length that do not overlap annotated protein-coding genes[3][5]. While lincRNAs in general have important roles in chromatin organization, transcriptional regulation, and enhancer-associated gene regulatory mechanisms, there is currently no detailed functional, disease, or pharmacological information available for LINC02061 itself[1][3]. LINC02061 is catalogued in gene databases based on transcriptional evidence, and, like other lincRNAs, it may be involved in fine-tuning gene expression and epigenetic control with high tissue specificity, but its specific biological role remains to be elucidated[3][5][7].

Other names
LINC02061Long intergenic non-protein coding RNA 2061
02

Mechanism of action

Not applicable. There are no approved drugs or well-characterized experimental molecules believed to act directly on LINC02061

03

Biological functions

Chromatin remodelingTranscription regulationRegulation of gene expression of neighboring genes via enhancer-like, cis, or trans mechanismsRNA stabilizationEpigenetic regulation
04

Disease associations

Other (lincRNAs broadly implicated in cancer, immune regulation, and development, but no disease association is documented specifically for LINC02061 in current sources)
05

Safety considerations

None reported. As LINC02061 is not a therapeutic or diagnostic target, there are no documented safety concerns or challenges in drug development for this molecule
06

Interacting drugs

None reported. No drugs are currently known to directly target LINC02061
07

Biomarkers

None reported. LINC02061 is not referenced as a biomarker for patient selection, efficacy, or disease monitoring

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2061 (LINC02061).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2061 (LINC02061).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call